Key result
Noninvasive electrophysiologic and echo tools show promise for detecting acute heart allograft rejection.
Why the study?
Acute allograft rejection remains a major cause of mortality in heart transplant recipients despite refinements in immunosuppressive therapy, necessitating improved diagnostic methods.
Do noninvasive diagnostic methods (electrophysiologic and echocardiographic techniques) accurately detect acute allograft rejection in heart transplant recipients compared to endomyocardial biopsy?
Do noninvasive diagnostic methods (electrophysiologic and echocardiographic techniques) accurately detect acute allograft rejection in heart transplant recipients compared to endomyocardial biopsy?
Noninvasive methods like electrophysiologic monitoring and echocardiography show promise in diagnosing heart graft rejection and may reduce reliance on endomyocardial biopsy.
No takes yet. Share an insight, caveat, or question.
Review underscores need for reliable noninvasive rejection monitoring post-heart transplant; leaves open which methods will meet all ideal criteria in practice.
Knosalla et al. (2000) conducted a review in Acute heart allograft rejection. Noninvasive diagnostic methods (electrophysiologic and echocardiographic techniques) was evaluated. Electrophysiologic and echocardiographic techniques are promising noninvasive methods for diagnosing acute heart allograft rejection, potentially reducing the need for endomyocardial biopsy.
Synapse has enriched one closely related paper. Consider it for comparative context: